PNP inhibitors additionally provide a novel approach for therapeutic TLR7 activation for use as a vaccine adjuvant (44) or for treatment of immunologically cold malignancies with upregulated PNP expression, such as pancreatic cancer (45). This evidence concerns the gene TLR7 and pancreatic neoplasm.